Yi Zhun Zhu
School of Pharmacy
Macau University of Science and Technology
Dr. Yi Zhun Zhu is a Chair Professor of Pharmacology and dean of School of Pharmacy, Macau University of Science and Technology. Dr. Zhu got his Bachelor of Medicine at Shanghai 2nd Medical University (now Shanghai Jiaotong University) in 1989 and M.D./Ph.D. from Faculty of Medicine, University of Heidelberg, Germany in 1995. He joined as a faculty member of the Department of Pharmacology, National University of Singapore (NUS) in 1998 after postdoc training at Kiel University and industrial experience at Hoechst Marion Roussel (now Sanofil). Dr. Zhu was recruited as dean and distinguished professor of pharmacology of School of Pharmacy, Fudan University and served until Feb. 2016. Dr. Zhu published more than 160 peer-reviewed papers with more than 4800 citations and edited 2 books for his work. He is an editor-in-chief for Cardiovasc. Regenerative Med. and associate editor for J Alzheimer Diseases, Biosci. Reports academic editor for PLoS One and editorial board member of CNS Neuroscience & Therapeutics, Journal of Pharmacology and Drug Metabolism, Frontiers in Neurotrauma etc. Dr. Zhu is also editor-in-chief for the national text book of Pharmacology (7th and 8th edition [Chinese version] and 1st edition [English version], People’s Medical Publishing House), Dr. Zhu was awarded ‘National Distinguished Young Scientist from Natural Science Foundation of China (NSFC) in 2008 and Chief Scientist of National Key Research Program (973) and Chief-PI for the National Platform of Drug Discovery in 2009. Dr. Zhu further received National Award for Innovative Research Work of the Returnees in 2009 from the State Council and Magnolia Award from Shanghai Government in 2010. Dr. Zhu was awarded 2011 Cheung Kong Chair Professorship by the Ministry of Education, China. In 2014, Dr. Zhu was awarded ‘Health China’ top 10 figures of the year. His research focuses on drug developments especially for heart and brain. Two novel compounds as drug candidates have been completed pre-clinical trials and are moving to clinical trials now.
Her main research interests include Drug developments especially for heart and brain